Literature DB >> 30604278

Brains for Dementia Research: The Importance of Cohorts in Brain Banking.

Paul T Francis1, Gillian M Hayes2, Helen Costello2, David R Whitfield2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30604278      PMCID： PMC6426925          DOI： 10.1007/s12264-018-0327-2

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN： 1995-8218            Impact factor:   5.203


× No keyword cloud information.
  40 in total

Review 1.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 2.  Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.

Authors:  Nicholas A Clarke; Paul T Francis
Journal:  Expert Rev Neurother       Date:  2005-09       Impact factor: 4.618

3.  Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease.

Authors:  Sara L Kirvell; Margaret Esiri; Paul T Francis
Journal:  J Neurochem       Date:  2006-08       Impact factor: 5.372

4.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

5.  Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

Authors:  Susan M Landau; Danielle Harvey; Cindee M Madison; Robert A Koeppe; Eric M Reiman; Norman L Foster; Michael W Weiner; William J Jagust
Journal:  Neurobiol Aging       Date:  2009-08-05       Impact factor: 4.673

6.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

Review 7.  The cholinergic hypothesis of Alzheimer's disease: a review of progress.

Authors:  P T Francis; A M Palmer; M Snape; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

8.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

Authors:  Clive Holmes; Delphine Boche; David Wilkinson; Ghasem Yadegarfar; Vivienne Hopkins; Anthony Bayer; Roy W Jones; Roger Bullock; Seth Love; James W Neal; Elina Zotova; James A R Nicoll
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

10.  Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.

Authors:  Irina Alafuzoff; Thomas Arzberger; Safa Al-Sarraj; Istvan Bodi; Nenad Bogdanovic; Heiko Braak; Orso Bugiani; Kelly Del-Tredici; Isidro Ferrer; Ellen Gelpi; Giorgio Giaccone; Manuel B Graeber; Paul Ince; Wouter Kamphorst; Andrew King; Penelope Korkolopoulou; Gábor G Kovács; Sergey Larionov; David Meyronet; Camelia Monoranu; Piero Parchi; Efstratios Patsouris; Wolfgang Roggendorf; Danielle Seilhean; Fabrizio Tagliavini; Christine Stadelmann; Nathalie Streichenberger; Dietmar R Thal; Stephen B Wharton; Hans Kretzschmar
Journal:  Brain Pathol       Date:  2008-03-26       Impact factor: 6.508
View more
  2 in total

1.  Progress in Human Brain Banking in China.

Authors:  Chao Ma; Ai-Min Bao; Xiao-Xin Yan; Dick F Swaab
Journal:  Neurosci Bull       Date:  2019-03-07       Impact factor: 5.203

2.  Toward establishing a worldwide net of canine biobanks.

Authors:  Sára Sándor; Silvan Urfer; Enikő Kubinyi
Journal:  Aging (Albany NY)       Date:  2022-03-17       Impact factor: 5.682
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.